Benzene-1,2,4,5-tetraamine tetrahydrochloride, 97.0%, 25g

5-(tert-Butyl)-2-hydroxybenzoic acid, 95.0%, 250mg

Methyl 4-((diethoxyphosphoryl)methyl)benzoate, 98%, 1g

2-(Bromomethyl)-1-methoxy-4-nitrobenzene, 95.0%, 100mg

(S)-Benzyl 3-methylpiperazine-1-carboxylate, 95.0%, 10g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 5g

Bomba de membrana para líquidos LIQUIPORT® versión NF 1.300, NF 1.300 TT.18 S, cabezal de bomba, PVDF, membrana, recubierta de PTFE, válvulas, FFKM, 1 pieza

tert-Butyl 5'-hydroxy-2'-(methylthio)-6'-oxo-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylate, 97%, 1g

N-Ethynyl-N,4-dimethylbenzenesulfonamide, 97%, 25g

1-(4-Fluoro-3-(trifluoromethyl)phenyl)-3-(5-(pyridin-4-yl)-1,3,4-thiadiazol-2-yl)urea, 98+%, 100mg

monoclonal de ratón anti-queratina K6, KA12, 1 ml

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 98%, 10mg

4-OXOPENTANAL, 95.0%, 50mg